NCT05029726View on ClinicalTrials.gov

Regional Anesthesia in Minimally Invasive Lumbar Spine Surgery

PHASE4RecruitingINTERVENTIONAL
Enrollment

125

Participants

Timeline

Start Date

February 1, 2022

Primary Completion Date

January 1, 2026

Study Completion Date

April 30, 2026

Conditions
Lumbar Spinal StenosisLumbar Disc HerniationLumbar SpondylolisthesisLumbar SpondylosisLumbar RadiculopathyLumbar Spine InstabilitySynovial CystDegenerative Disc DiseaseDegenerative SpondylolisthesisDegenerative Intervertebral Discs
Interventions
DRUG

Bupivacaine-Epinephrine 0.25%-1:200,000 Injectable Solution plus clonidine

Bupivacaine-Epinephrine 0.25%-1:200,000 plus clonidine 50 micrograms in 30cc syringes administered as ESPB

DRUG

normal saline

normal saline in 30cc syringes administered using ESPB technique

Trial Locations (1)

60612

RECRUITING

Rush University Medical Center, Chicago

All Listed Sponsors
lead

John O'Toole

OTHER